Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Exit strategy advice: 2nd transplant vs. electrolysis to soften hairline

      in General  99 upvotes 7 months ago
      A 32-year-old male is considering options to soften a dense transplanted hairline after experiencing accelerated hair loss and intolerance to finasteride and dutasteride, while using minoxidil. He is exploring partial electrolysis or laser treatments to achieve a natural look with a short buzz cut, avoiding a second transplant or scalp micropigmentation.

      community Gyno & testoterone level

      in Finasteride  282 upvotes 2 years ago
      Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.

      community 16 months of treatment and a frontal transplant changed my life!!

      in Progress Pictures  642 upvotes 4 months ago
      A 30-year-old shared their successful hair restoration journey using liposomal topical finasteride and minoxidil, vitamins, and a second hair transplant in Greece, which significantly improved their hair density without side effects. The transplant cost $7500 and involved filling an old scar, with the user expressing gratitude for the life-changing results.

      community Regrowth or nah? 8 months fin 0.5mg

      in Is this regrowth?  45 upvotes 1 year ago
      A user has been taking 0.5mg oral Finasteride daily for 8 months and is unsure if fine, soft, colorless hairs are regrowth. Other users suggest trying oral Minoxidil for faster results and mention their own experiences with oral treatments.

      community PP405 Phase 2a press release with early results

      in Research/Science  700 upvotes 11 months ago
      PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.